Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

03/08/2018 08:00

Aug 3 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.26               15.97            68.00    
                 (-4.5 pct)          (-3.1 pct)       (+5.3 pct)  
  Operating          1.63              597 mln            5.20    
                (+173.5 pct)         (-65.3 pct)      (+7.7 pct)  
  Recurring          1.74              663 mln            5.20    
                (+162.4 pct)         (-63.8 pct)      (+2.2 pct)  
  Net                2.24              657 mln            4.30    
                (+241.3 pct)         (-50.5 pct)      (+3.4 pct)  
  EPS             44.59 yen           12.39 yen        85.50 yen  
  Ann Div                             34.00 yen        34.00 yen  
  -Q2 div                             17.00 yen        17.00 yen  
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T